Has the FDA or other regulators approved any diabetes treatments promoted by Dr. Oz?

Checked on January 6, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

No credible evidence shows that the U.S. Food and Drug Administration or other regulators have approved any diabetes treatment that was created by or officially promoted by Dr. Mehmet Oz; multiple fact-checks and academic write-ups identify viral ads and videos that falsely tie him to “miracle” cures or unregistered products such as Glufarelin and label some clips as deepfakes [1] [2] [3] [4].

1. The central claim and what the records say

The recurring online claim that Dr. Oz is behind an FDA‑approved diabetes drug or breakthrough treatment does not stand up to scrutiny: a health-focused explainer explicitly states Dr. Oz “has not created or endorsed any FDA‑approved diabetes medication” [1], Poynter’s fact‑check finds “no evidence” he promoted a diabetes breakthrough and identifies a deepfaked clip [2], and academic reporting documents AI-manipulated videos that misattribute miracle cures to him [4].

2. The common misinformation vectors: deepfakes and unregistered products

Investigations show two complementary misinformation patterns driving the confusion: first, manipulated or asynchronous videos that superimpose or re‑sync Dr. Oz to false claims about instant cures—scholars and medical commentators have flagged such clips as deepfakes or heavily edited [4]; second, fabricated endorsements linking him to unregistered commercial products like “Glufarelin,” which fact‑checkers report is not on FDA lists and for which attribution to Oz is fabricated [3].

3. Where real regulatory approvals exist, and how they differ from the hype

There are genuine, regulator‑approved advances in diabetes care—public reporting notes, for example, that teplizumab was approved in 2022 for delaying onset of type 1 diabetes in some patients [5]—but those approvals are independent of the viral claims and not presented in the sourced reporting as having been promoted by Dr. Oz [5]. The sources reviewed do not show regulators approving any product that Dr. Oz created, owned, or credibly endorsed.

4. How commercial clickbait and marketing amplify the false narrative

Several sources trace the “Dr. Oz diabetes drug” phrase to clickbait, email promotions, and aggressive online ads that borrow his brand recognition to sell remedies or supplements; analysis warns that many so‑called “Dr. Oz remedies” are marketed as supportive or supplemental rather than as FDA‑approved therapies, and the promotional language often conflates lifestyle advice with regulated medical treatments [1] [6].

5. What the reporting cannot confirm and caution for readers

The assembled sources consistently debunk the specific claim that regulators approved a diabetes drug promoted by Dr. Oz but do not catalog every product ever marketed with his name attached; they also do not provide an exhaustive FDA database search within these excerpts, so while fact‑checks and academic pieces show prominent examples of fabrication and deepfakes, the reporting cannot—based on the provided material—absolutely rule out every single commercial use of his name absent further document searches [2] [4] [3].

6. Bottom line and practical implication

Based on fact‑checks, academic analyses, and reporting collated here, there is no verified instance in the provided sources of an FDA or equivalent regulatory approval for a diabetes treatment created by or legitimately promoted as a breakthrough by Dr. Oz; the prevailing evidence points to deepfakes, fabricated endorsements, and unregistered products being passed off online as authoritative [1] [2] [3] [4].

Want to dive deeper?
Which specific social media deepfakes have been debunked regarding medical claims and who produced them?
What FDA resources and databases can consumers use to verify whether a diabetes drug or supplement is registered or approved?
How have celebrity endorsements historically affected the marketing and regulatory scrutiny of health products?